Literature DB >> 7174128

The response of seven prostatic fluid components to prostatic disease.

J P Kavanagh, C Darby, C B Costello.   

Abstract

282 human prostatic fluid samples have been investigated for their pH value, zinc, and citrate concentration and their acid phosphatase, leucine aminopeptidase, diamine oxidase, and beta-glucuronidase activities. The results have been analysed in terms of the clinical status of the patients. Significant differences between patient categories were found with all but diamine oxidase and beta-glucuronidase. These differences were mainly found between men with apparently healthy prostates and prostatitis patients; the pH being raised and the acid phosphatase, leucine aminopeptidase, zinc and citrate being reduced. The diagnostic value of these parameters was evaluated, each could be used to classify correctly 90% of patients from these 2 groups. Zinc, citrate and leucine aminopeptidase showed no age relationship and were better than acid phosphatase and pH in discriminating between BPH and prostatitis. Evidence was also found for a return of normal secretory function sometime after an episode of prostatitis. Zinc and citrate are likely to be the most useful parameters for clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7174128     DOI: 10.1111/j.1365-2605.1982.tb00280.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  12 in total

Review 1.  The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy.

Authors:  L C Costello; R B Franklin
Journal:  Oncology       Date:  2000-11       Impact factor: 2.935

2.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

3.  Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer.

Authors:  V Y Zaichick; T V Sviridova; S V Zaichick
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

4.  Thermoacoustic contrast of prostate cancer due to heating by very high frequency irradiation.

Authors:  S K Patch; D Hull; M Thomas; S K Griep; K Jacobsohn; W A See
Journal:  Phys Med Biol       Date:  2015-01-02       Impact factor: 3.609

5.  Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels.

Authors:  F K Habib; C M Goodman; C Buck
Journal:  Urol Res       Date:  1992

6.  Zinc in post prostatic massage (VB3) urine samples: a marker of prostatic secretory function and indicator of bacterial infection.

Authors:  J P Kavanagh; C Darby; C B Costello; S D Chowdhury
Journal:  Urol Res       Date:  1983

Review 7.  Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem.

Authors:  L C Costello; R B Franklin
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-07-01       Impact factor: 5.554

8.  Antichlamydial antibodies and citric acid in patients with chronic prostatitis.

Authors:  Iwona Ostaszewska-Puchalska; Bozena Zdrodowska-Stefanow; Jerzy Badyda; Zofia Galewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

9.  Peptide-based, two-fluorophore, ratiometric probe for quantifying mobile zinc in biological solutions.

Authors:  Daniel Y Zhang; Maria Azrad; Wendy Demark-Wahnefried; Christopher J Frederickson; Stephen J Lippard; Robert J Radford
Journal:  ACS Chem Biol       Date:  2014-11-10       Impact factor: 5.100

10.  The evaluation of markers of prostatic inflammation and function of the prostate gland in patients with chronic prostatitis.

Authors:  Bozena Zdrodowska-Stefanow; Iwona Ostaszewska-Puchalska; Jerzy Badyda; Zofia Galewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-07-29       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.